mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.5 |
mRNA |
AG-014699 |
GDSC1000 |
pan-cancer |
AAC |
0.027 |
0.5 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
necrostatin-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.5 |
mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.5 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.5 |
mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.5 |
mRNA |
EX-527 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.5 |